Product Information
FT INF IBUPROFEN 50 MG/1.25 ML is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1993 per ML under NDC 70677114601. Its NADAC has been published 100 times since Nov 6, 2024.
FDA first approved this application on Dec 16, 1998.
The High Outlier badge above means this manufacturer's average price in the Ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1.25mL
Manufacturer
Strategic Sourcing Services LLCNDC
70677114601
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA075217FDA Approved
12/16/1998
On Market Since
2/7/2024
Pharmacological Classes
Price Statistics
The NADAC for FT INF IBUPROFEN 50 MG/1.25 ML has been published 100 times since Nov 6, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1993 per ML |
|---|---|
| All-time high | $0.2035 (Jun 11, 2025) |
| All-time low | $0.1979 (Nov 20, 2024) |
| 52-week high | $0.2031 |
| 52-week low | $0.1993 |
| Median price | $0.2012 |
| Average price | $0.2010 |
| Largest weekly change | -0.9% (Dec 17, 2025) |
| Weeks tracked | 100 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT INF IBUPROFEN 50 MG/1.25 ML?
The current National Average Drug Acquisition Cost (NADAC) for FT INF IBUPROFEN 50 MG/1.25 ML, manufactured by Strategic Sourcing Services LLC, is $0.1993 per ML (NDC 70677114601), effective Sep 30, 2026.
How has the price of FT INF IBUPROFEN 50 MG/1.25 ML changed over time?
Over the history we have for it, the NADAC for FT INF IBUPROFEN 50 MG/1.25 ML has held within roughly two percent of its current level. It has been tracked across 100 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for FT INF IBUPROFEN 50 MG/1.25 ML?
Since Nov 6, 2024, the NADAC for FT INF IBUPROFEN 50 MG/1.25 ML has ranged from a low of $0.1979 (Nov 20, 2024) to a high of $0.2035 (Jun 11, 2025), with a median of $0.2012 per ML.
Are there cheaper alternatives to FT INF IBUPROFEN 50 MG/1.25 ML?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INFANT IBUPROFEN 50 MG/1.25 ML, is $0.1880 per ML — about 6% below FT INF IBUPROFEN 50 MG/1.25 ML.
Who manufactures FT INF IBUPROFEN 50 MG/1.25 ML?
FT INF IBUPROFEN 50 MG/1.25 ML (NDC 70677114601) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.